A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of the study was to evaluate whether timolol hemihydrate is more comfortable upon instillation than timolol maleate in sorbate. This was an observational study. Subjects with open-angle glaucoma or ocular hypertension were asked to complete a survey regarding their normal treatment. No treatment was prescribed.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Vistakon Pharmaceuticals
• Treatments: Maleic acid; Timolol

Criteria

Inclusion Criteria:

• willing to comply with investigator's and protocol's instructions

• patients signature on the informed consent document

• open-angle glaucoma or ocular hypertension

• currently prescribed timolol hemihydrate (once a day (QD) or twice a day (BID))or timolol maleate in sorbate QD as monotherapy or as a part of 2-drug therapy in at least one eye

Exclusion Criteria:

• inability to understand the trial procedures

• inability to give informed consent

• inability to understand, read, or write English

• best corrected visual acuity of 20/200 or worse in each eye

• current moderate to severe infectious or inflammatory condition of the eye or eyelids including

• current moderate to severe dry eye syndrome

• current chronic use of ocular corticosteroids, ocular surgery or intraocular laser surgery to either eye in the prior 3 months

• treated with 3 or more glaucoma medicines in both eye